IPCA Labs - Q4FY13 Result Preview - Angel Broking

We estimate Ipca Laboratories' top-line to grow by 39.2% to Rs. 770cr for 4QFY2013. The OPM is expected to expand by 30bp yoy to 19.0%. The adjusted net profit is expected to grow by 58.0% yoy on back of top-line growth.

We maintain an accumulate on the stock with a target of 676.

Source : Equity Bulls

Keywords